Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Williams, Rachel ^a   Rohr, Aaron M ^a   Wang, Wen Tung ^b   Choi, In Young ^a,b   Lee, Phil ^a,b   Berman, Nancy E J ^a   Lynch, Sharon G ^a   LeVine, Steven M ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENCEPHALITOGENIC PROTEIN; GAMMA INTERFERON; IRON; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; BRAIN BLOOD FLOW; CONTROLLED STUDY; FEMALE; HEMISPHERE; HISTOCHEMISTRY; INFLAMMATORY INFILTRATE; IRON STORAGE; LASER DOPPLER FLOWMETRY; MICROGLIA; MICROGLIOSIS; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ANIMAL; ASTROCYTE; BRAIN CIRCULATION; BRAIN CORTEX; INFLAMMATION; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ASTROCYTES; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; IRON; MICE; MULTIPLE SCLEROSIS; NEURONS;

EID: 79959404049     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-59     Document Type: Article

References (42)

1. Inglese M, Park SJ, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007, 64(2):196-202. 10.1001/archneur.64.2.196, 17296835.
2. Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004, 231(3):645-652. 10.1148/radiol.2313030996, 15163806.
3. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'Ara S, Bartolomei I, Salvi F. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009, 80(4):392-399. 2647682, 19060024.
4. Zamboni P, Menegatti E, Bartolomei I, Galeotti R, Malagoni AM, Tacconi G, Salvi F. Intracranial venous haemodynamics in multiple sclerosis. Curr Neurovasc Res 2007, 4(4):252-258. 10.2174/156720207782446298, 18045150.
5. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988, 51(2):260-265. 10.1136/jnnp.51.2.260, 1031540, 3346691.
6. Haacke EM, Garbern J, Miao Y, Habib C, Liu M. Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. Int Angiol 2010, 29(2):149-157.
7. Haacke EM, Makki M, Ge Y, Maheshwari M, Sehgal V, Hu J, Selvan M, Wu Z, Latif Z, Xuan Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009, 29(3):537-544. 10.1002/jmri.21676, 2650739, 19243035.
8. Singh AV, Zamboni P. Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab 2009, 29(12):1867-1878. 10.1038/jcbfm.2009.180, 19724286.
9. Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 2006, 99(11):589-593. 10.1258/jrsm.99.11.589, 1633548, 17082306.
10. Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, et al. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol 2010, 29(2):158-175.
11. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, Mascoli F, Salvi F. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009, 50(6):1348-1358 e1341-1343. 10.1016/j.jvs.2009.07.096, 19958985.
12. Adams CWM. A Color Atlas of Multiple Sclerosis and Other Myelin Disorders 1989, Dobbs Ferry, NY: Sheridan Medical Books.
13. Henke PK, Varga A, De S, Deatrick CB, Eliason J, Arenberg DA, Sukheepod P, Thanaporn P, Kunkel SL, Upchurch GR, et al. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol 2004, 24(6):1130-1137. 10.1161/01.ATV.0000129537.72553.73, 15105284.
14. Wakefield AJ, More LJ, Difford J, McLaughlin JE. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994, 47(2):129-133. 10.1136/jcp.47.2.129, 501826, 8132826.
15. Tanaka R, Iwasaki Y, Koprowski H. Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 1975, 81(3):467-478. 2032346, 1211421.
16. Adams CW, Poston RN, Buk SJ. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 1989, 92(2-3):291-306. 10.1016/0022-510X(89)90144-5, 2809622.
17. Emerson MR, Gallagher RJ, Marquis JG, LeVine SM. Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design. Comp Med 2009, 59(2):112-128. 2703151, 19389303.
18. Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982, 106(8):397-399.
19. Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, Babb JS, Herbert J, Grossman RI. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007, 28(9):1639-1644. 10.3174/ajnr.A0646, 17893225.
20. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997, 760(1-2):298-303. 10.1016/S0006-8993(97)00470-8, 9237552.
21. Mitchell KM, Dotson AL, Cool KM, Chakrabarty A, Benedict SH, LeVine SM. Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult Scler 2007, 13(9):1118-1126. 10.1177/1352458507078916, 17967839.
22. Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, Anthony DC, Linington C, Bruck W, Schwab ME. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 2004, 164(4):1455-1469. 10.1016/S0002-9440(10)63232-4, 1615356, 15039233.
23. Onyszchuk G, LeVine SM, Brooks WM, Berman NE. Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci Lett 2009, 452(2):204-208. 10.1016/j.neulet.2009.01.049, 2829973, 19383440.
24. Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, Thomsen KM, Mandrekar JN, Erickson BJ, Lucchinetti CF. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 133(Pt 2):333-348.
25. Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J. Venous and cerebrospinal fluid flow in multiple sclerosis: A case-control study. Ann Neurol 68(2):255-259.
26. Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 68(2):173-183.
27. Zamboni P, Menegatti E, Galeotti R, Malagoni AM, Tacconi G, Dall'Ara S, Bartolomei I, Salvi F. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci 2009, 282(1-2):21-27. 10.1016/j.jns.2008.11.027, 19144359.
28. Bakshi R, Shaikh ZA, Janardhan V. MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000, 11(1):15-21. 10.1097/00001756-200001170-00004, 10683822.
29. Chin CL, Pai M, Bousquet PF, Schwartz AJ, O'Connor EM, Nelson CM, Hradil VP, Cox BF, McRae BL, Fox GB. Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways. J Neuroimmunol 2009, 211(1-2):49-55. 10.1016/j.jneuroim.2009.03.012, 19346009.
30. Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ, Jacobs L. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002, 59(1):62-68. 10.1001/archneur.59.1.62, 11790232.
31. LeVine SM, Torres MV. Morphological features of degenerating oligodendrocytes in twitcher mice. Brain Res 1992, 587(2):348-352. 10.1016/0006-8993(92)91018-A, 1525668.
32. Taniike M, Suzuki K. Spacio-temporal progression of demyelination in twitcher mouse: with clinico-pathological correlation. Acta Neuropathol 1994, 88(3):228-236. 10.1007/BF00293398, 7528964.
33. Kobayashi S, Chiu FC, Katayama M, Sacchi RS, Suzuki K. Expression of glial fibrillary acidic protein in the CNS and PNS of murine globoid cell leukodystrophy, the twitcher. Am J Pathol 1986, 125(2):227-243. 1888232, 3538889.
34. LeVine SM, Brown DC. IL-6 and TNFalpha expression in brains of twitcher, quaking and normal mice. J Neuroimmunol 1997, 73(1-2):47-56. 10.1016/S0165-5728(96)00166-X, 9058758.
35. Villarroya H, Marie Y, Ouallet JC, Le Saux F, Tchelingerian JL, Baumann N. Expression of TNF alpha in central neurons of Lewis rat spinal cord after EAE induction. J Neurosci Res 1997, 49(5):592-599. 10.1002/(SICI)1097-4547(19970901)49:5<592::AID-JNR9>;3.0.CO;2-6, 9302080.
36. Raine CS, Bonetti B, Cannella B. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev Neurol (Paris) 1998, 154(8-9):577-585.
37. Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 2002, 91(1):9-18. 10.1016/S0162-0134(02)00461-0, 12121757.
38. Saleppico S, Mazzolla R, Boelaert JR, Puliti M, Barluzzi R, Bistoni F, Blasi E. Iron regulates microglial cell-mediated secretory and effector functions. Cell Immunol 1996, 170(2):251-259. 10.1006/cimm.1996.0159, 8660825.
39. Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N, Connor JR. Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 2005, 52(3):199-208. 10.1002/glia.20235, 15968631.
40. Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR. Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 2006, 54(8):795-804. 10.1002/glia.20416, 16958088.
41. LeVine SM, Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci 2004, 1012:252-266. 10.1196/annals.1306.021, 15105271.
42. Juhler M, Paulson OB. Regional cerebral blood flow in acute experimental allergic encephalomyelitis. Brain Res 1986, 363(2):272-278. 10.1016/0006-8993(86)91012-7, 3484654.